{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:06:47Z","timestamp":1794020807427,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008725","name":"Maj Institute of Pharmacology Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004382","name":"Polska Akademia Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2020\/37\/B\/NZ7\/03753"],"award-info":[{"award-number":["2020\/37\/B\/NZ7\/03753"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111347","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:30:04Z","timestamp":1743215404000},"page":"111347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The effect of low-dose psilocybin on brain neurotransmission and rat behavior"],"prefix":"10.1016","volume":"138","author":[{"given":"Agnieszka","family":"Bysiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wojtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Szpr\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wawrzczak-Bargie\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Ma\u0107kowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Go\u0142embiowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111347_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-4328(96)00112-X","article-title":"Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH\/corticosterone responses","volume":"73","author":"Bagdy","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.euroneuro.2017.11.013","article-title":"Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia","volume":"28","author":"Bator","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0015","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1523\/JNEUROSCI.5113-03.2004","article-title":"Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors","volume":"24","author":"Beique","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229067","article-title":"Self-reported negative outcomes of psilocybin users: a quantitative textual analysis","volume":"15","author":"Bienemann","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0025","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.3390\/ijms22168710","article-title":"Inhibition of BET proteins during adolescence affects prefrontal cortical development: relevance to schizophrenia","volume":"22","author":"Bilecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/164_2018_107","article-title":"Serotonergic psychedelics: experimental approaches for assessing mechanisms of action","volume":"252","author":"Canal","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0050","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acschemneuro.5b00099","article-title":"An orally active phenylaminotetralin-chemotype serotonin 5-HT7 and 5-HT1A receptor partial agonist that corrects motor stereotypy in mouse models","volume":"6","author":"Canal","year":"2015","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"235","key":"10.1016\/j.pnpbp.2025.111347_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"2018","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnint.2013.00025","article-title":"Serotonin modulation of cortical neurons and networks","volume":"7","author":"Celada","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0269881107077718","article-title":"(+\/\u2212) ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics","volume":"21","author":"Cilia","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113894","article-title":"Neurotoxicity of MDMA: Main effects and mechanisms","volume":"347","author":"Costa","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","article-title":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications","volume":"151","author":"De Deurwaerd\u00e8re","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0090","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/acschemneuro.8b00186","article-title":"DARK classics in chemical neuroscience: psilocybin","volume":"9","author":"Geiger","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0361-9230(90)90241-Q","article-title":"Startle response models of sensorimotor gating and habituation deficits in schizophrenia","volume":"25","author":"Geyer","year":"1990","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2011.08.040","article-title":"Simultaneous quantification of D- vs. L-serine, taurine, kynurenate, phosphoethanolamine and diverse amino acids in frontocortical dialysates of freely-moving rats: differential modulation by N-methyl-D-aspartate (NMDA) and other pharmacological agents","volume":"202","author":"Gobert","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00008877-199811000-00011","article-title":"Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans","volume":"9","author":"Gouzoulis-Mayfrank","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.1996.tb15241.x","article-title":"Receptor autoradio- graphic and in situ hybridization analysis of the distribution of the 5-ht7receptor in rat brain","volume":"117","author":"Gustafson","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","article-title":"A complex impact of systemically administered 5-HT2A receptor ligands on conditioned fear","volume":"24","author":"Hags\u00e4ter","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2016_64","article-title":"Pharmacology and toxicology of N-Benzylphenethylamine (\u201cNBOMe\u201d) hallucinogens","volume":"32","author":"Halberstadt","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose\u2013effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0269881107077734","article-title":"Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis","volume":"21","author":"Heekeren","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12640-019-00033-x","article-title":"Hallucinogen-like action of the novel designer drug 25I-NBOMe and its effect on cortical neurotransmitters in rats","volume":"36","author":"Herian","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0165","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s43440-020-00181-4","article-title":"Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission","volume":"72","author":"Herian","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-2952(61)90124-1","article-title":"The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates","volume":"7","author":"Horita","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","article-title":"Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice","volume":"6","author":"Jones","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/7854_2022_366","article-title":"Psilocybin for trauma-related disorders","volume":"56","author":"Khan","year":"2022","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0190","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00213-017-4610-0","article-title":"Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation","volume":"34","author":"Kraehenmann","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2017.11.018","article-title":"Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer\u2019s disease","volume":"1","author":"Lebois","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2023.09.004","article-title":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study","volume":"114","author":"Mason","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jnr.10126","article-title":"In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation","volume":"67","author":"Meller","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0215","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02805983","article-title":"Circadian rhythm in the responsiveness of central 5-HT(2A) receptor to DOI in rats","volume":"127","author":"Nagayama","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/syn.20054","article-title":"Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat","volume":"53","author":"Nair","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321803","article-title":"Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics","volume":"63","author":"Palenicek","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0306-3623(96)00460-0","article-title":"5-HT1B\/D receptor antagonists","volume":"29","author":"Pauwels","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0250","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2016_459","article-title":"Phenomenology, structure, and dynamic of psychedelic states","volume":"36","author":"Preller","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0260","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontalcortexby5-HT2A receptors. Relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cereb. Cortex."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(85)91590-2","article-title":"Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex","volume":"333","author":"Quirion","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0270","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0309-1651(89)90024-6","article-title":"Presynaptic regulation of acetylcholine release in the CNS","volume":"13","author":"Raiteri","year":"1989","journal-title":"Cell Biol. Int. Rep."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0275","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0280","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-0270(94)00132-Z","article-title":"Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehydesulphite derivatization","volume":"57","author":"Rowley","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0290","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0295","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0300","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/np030059u","article-title":"Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of \u201cmagic mushroom\u201d","volume":"66","author":"Shirota","year":"2003","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02245096","article-title":"8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,35 and localization of site of action","volume":"117","author":"Sipes","year":"1995","journal-title":"Psychopharmaology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0310","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","article-title":"Realistic expectations of prepulse inhibition in translational models for schizophrenia research","volume":"199","author":"Swerdlow","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0315","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neuroimage.2018.01.080","article-title":"A common brain network among state, trait, and pathological anxiety from whole-brain functional connectivity","volume":"172","author":"Takagi","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0320","article-title":"Effect of -NBOMe compounds on sensorimotor, motor, and prepulse inhibition responses in mice in comparison with the 2C analogs and lysergic acid diethylamide: from preclinical evidence to forensic implication in driving under the influence of drugs","volume":"13","author":"Tirri","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0325","article-title":"Acute psilocybin enhances cognitive flexibility in rats","author":"Torrado Pacheco","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0330","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","article-title":"Psilocybin\u2014summary of knowledge and new perspectives","volume":"24","author":"Tyl\u0161","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0335","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00213-019-05414-w","article-title":"Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","volume":"237","author":"Uthaug","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0340","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1523\/JNEUROSCI.21-10-03572.2001","article-title":"5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells","volume":"21","author":"Van de Kar","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2020.1817639","article-title":"Efficacy of psychoactive drugs for the treatment of posttraumatic stress disorder: a systematic review of MDMA, ketamine, LSD and psilocybin","volume":"53","author":"Varker","year":"2021","journal-title":"J. Psychoactive Drugs."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0350","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/a-1721-2914","article-title":"Classic psychedelic drugs: update on biological mechanisms","volume":"55","author":"Vollenweider","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0360","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.npp.1301324","article-title":"The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval","volume":"32","author":"Vollenweider","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0365","article-title":"Single dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, doubleblind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pnpbp.2025.111347_bb0370","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jnr.23840","article-title":"Cholinergic regulation of fear learning and extinction","volume":"95","author":"Wilson","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12640-020-00297-8","article-title":"Neurochemical and behavioral effects of a new hallucinogenic compound 25B-NBOMe in rats","volume":"39","author":"Wojtas","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0380","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of psilocybin and ketamine on brain neurotransmitters, glutamate receptors, DNA and rat behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0385","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms25010100","article-title":"Limbic system response to psilocybin and ketamine administration in rats: a neurochemical and behavioral study","volume":"25","author":"Wojtas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111347_bb0390","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1523\/JNEUROSCI.22-21-09635.2002","article-title":"Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (\u2212)DOI","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:28:23Z","timestamp":1762284503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":78,"alternative-id":["S0278584625001010"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111347","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of low-dose psilocybin on brain neurotransmission and rat behavior","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111347"}}